BioAsia Biotech CO., LTD. (known as "BioAsia") was established in 2010, initiated by Shanghai BioAsia Pharmaceutical Group, and is headquartered in Pinghu, Zhejiang Province. The company focuses on systematic research, industrialization, and internationalization of Cordyceps fungi (especially Cordyceps cicadae), powered by microbial resources and synthetic biology, aiming to become a benchmark enterprise in the global biomanufacturing industry.
Cordyceps cicadae is an entomogenous fungus and the source of the traditional Chinese medicine "Jianhua" (cicada flower). It belongs to the same Cordyceps family as Ophiocordyceps sinensis (winter worm summer grass). BioAsia has achieved artificial cultivation and industrialization of Cordyceps cicadae, and its cultivation technology won the China Patent Gold Award.
In 2021, the cultivated Cordyceps cicadae fruiting body originally developed by BioAsia was approved by the state as a "New Food Raw Material", making it legally usable in food and health food products.
BioAsia has built a microbial strain resource bank and a solid-state bioengineering fermentation center, and holds 357 intellectual property patents covering core invention patents, Cordyceps strain resources, and solid-state fermentation technology. The Cordyceps cicadae strain is also protected under Plant Variety Rights.
BioAsia operates four core segments: food and health food, biomaterials and biomanufacturing, bio-agriculture, and science and popular science education.
Main products include: cultivated Cordyceps cicadae fruiting body raw material, Cordyceps cicadae, Cordyceps cicadae plant beverage, dual-Cordyceps probiotic solid beverage, Biao Brand Cordyceps cicadae wine, Cordyceps farm series (farm chicken, lamb, eggs), and the Pien Tze Huang Cordyceps series (pure powder and wine).
The headquarters is located at No. 1938 Xinqun Road, Economic & Technological Development Zone, Pinghu, Zhejiang. R&D and industrial bases are located in Pinghu (HQ), Huai'an (Jiangsu), Shanghai, and Eskilstuna (Sweden). Subsidiaries include Zhejiang BioAsia Health Food Co., Shanghai BioAsia Bioengineering Co., Jiangsu BioAsia Cordyceps Health Farm, and Plantamed AB (Sweden).
Zhejiang BioAsia Life Science Research Institute conducts research on Cordyceps cicadae in six directions: core pharmacology and disease intervention, immune regulation, artificial cultivation, safety and toxicology evaluation, omics and gene function, and pharmacology and clinical research, with numerous published papers.
Contact us by phone at 4009-263-838 or +86-573-85208111, or by email at marketing@bioasia.com.cn. You can also leave a message on the Contact page. Business hours: Monday to Friday, 08:30 - 17:00 (CST).
Major awards include: the 20th China Patent Gold Award (Cordyceps cicadae cultivation technology), approval of cultivated Cordyceps cicadae fruiting body as New Food Raw Material, Plant Variety Protection for the Cordyceps cicadae strain, National High-tech Enterprise certification, Academician Expert Workstation, and Zhejiang Provincial Science Popularization Education Base.